Invention Grant
US08236792B2 Substituted pyrrolidine amides as modulators of the histamine H3 receptor
有权
取代的吡咯烷酰胺作为组胺H3受体的调节剂
- Patent Title: Substituted pyrrolidine amides as modulators of the histamine H3 receptor
- Patent Title (中): 取代的吡咯烷酰胺作为组胺H3受体的调节剂
-
Application No.: US12468632Application Date: 2009-05-19
-
Publication No.: US08236792B2Publication Date: 2012-08-07
- Inventor: Nicholas I Carruthers , Michael A. Letavic , Kiev S. Ly , Neelakandha S. Mani , Daniel J. Pippel , Chandravadan R. Shah , Akinola Soyode-Johnson , Emily M. Stocking , Lana Young
- Applicant: Nicholas I Carruthers , Michael A. Letavic , Kiev S. Ly , Neelakandha S. Mani , Daniel J. Pippel , Chandravadan R. Shah , Akinola Soyode-Johnson , Emily M. Stocking , Lana Young
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agent Michael J. Atkins
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K31/497 ; A61K31/445 ; A61K31/40 ; C07D243/08 ; C07D403/00 ; C07D401/00 ; C07D205/00
Abstract:
Certain substituted pyrrolidine amide compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.
Public/Granted literature
- US20090291903A1 SUBSTITUTED PYRROLIDINE AMIDES AS MODULATORS OF THE HISTAMINE H3 RECEPTOR Public/Granted day:2009-11-26
Information query
